Allied Biotech

Allied Biotech Net Margin

The Net Profit Margin of Allied Biotech (1780.TWO) as of Nov 3, 2026 is 15.24 %. In the previous year, Net Profit Margin was 12.51 % — a change of 21.82% (higher).

Net Margin

15.24 %

YoY

21.82%

Last updated:

Net Profit Margin of Allied Biotech is 2025 15.24 % . Net Profit Margin of Allied Biotech was 2024 12.51 % . It decreases by 21.82% higher compared to the previous year.

Allied Biotech's net margin stands at 15.2%, up from 1.9% several years earlier.

The Allied Biotech Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
17.44 TWD
Jan 1, 2019
16.72 TWD
Jan 1, 2020
12.86 TWD
Jan 1, 2021
1.93 TWD
Jan 1, 2022
20.47 TWD
Jan 1, 2023
13.52 TWD
Jan 1, 2024
12.51 TWD
Jan 1, 2025
15.24 TWD
The Allied Biotech Net Margin history
YEARNet MarginYoY
15.24 %+21.82%
12.51 %-7.49%
13.52 %-33.96%
20.47 %+962.37%
1.93 %-85.01%
12.86 %-23.09%
16.72 %-4.15%
17.44 %+67.40%
10.42 %+48.56%
7.01 %-20.67%
8.84 %+498.06%
1.48 %+11,047.08%
0.01 %-83.96%
0.08 %+127.91%
0.04 %+24,225.46%
0.00-98.57%
0.01 %+38.72%
0.01 %-104.83%
-0.16 %+45.90%
-0.11 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Allied Biotech Stock analysis

What does Allied Biotech do? Allied Biotech Corp manufactures carotenoid formulations for food, supplements, feeds, and cosmetics, with major products including beta-carotene, canthaxanthin, lycopene, lutein, coenzyme Q10, natural vitamin E, and food additives. The company sells these products to domestic markets and overseas regions such as Asia, Europe, and the Americas, targeting customers in food processing, supplement manufacturing, animal nutrition, and cosmetic industries. Its nutraceutical products serve human healthcare, animal nutraceuticals, veterinary drugs, pharmaceutical cosmetics, and biotechnology sectors. The firm's carotenoids are specifically applied in food and beverage processing, enhancing product formulations for nutritional and coloration purposes. Allied Biotech Corp's revenue streams come from the sale of these specialized formulations to manufacturers and distributors across multiple industries, including food and beverage, animal feed, and cosmetic production. The company focuses on delivering high-value biotechnology-based ingredients to global markets through its product portfolio. Allied Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Allied Biotech stock

Net Profit Margin of Allied Biotech is 15.24 % in 2025.

Net Profit Margin of Allied Biotech changed from 12.51 % to 15.24 %, representing a 21.82% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Allied Biotech since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Allied Biotech with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Allied Biotech

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Allied Biotech